Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01822171 · ClinicalTrials.gov registry record · NA

Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients

A NA study, sponsored by Providence Health & Services.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT01822171: Clinical Trial NA study, sponsored by Providence Health & Services.

NCT01822171 is a NA study that was terminated before completion, run by Providence Health & Services. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01822171, a NA study, was terminated before completion, sponsored by Providence Health & Services.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a pharmacist, home medications at discharge, and seeing the patient again in a pharmacist-run Medication Therapy Management (MTM) clinic 7 days after discharge, the study anticipates achieving its primary goal of showing a reduction in the readmission rate. Secondary goals are: 1) to determine patients understanding of the medication they are taking, 2) to evaluate satisfaction with the comprehensive discharge counseling service, and 3) determine the number of interventions made and benefit of the MTM clinic.

Primary Outcome

The readmission rate for the 50 subjects involved in this study will be compared to an equal number patients retrospectively reviewed from a 2011 patient list and matched for heart failure severity. The primary outcome will based on a comparison of the ratio of patients readmitted to the hospital before the discharge instruction program started and after.

Interventions

  • OTHER Discharge medication counseling from a pharmacist
  • OTHER Home medication if needed
  • OTHER Follow-up visit at Medication Therapy Management clinic

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2013-01
Est. Completion 2013-05
Phase NA
Providence Health & Services

69 total trials

Why NCT01822171 stopped before completion

NCT01822171 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 3 interventions - of which Discharge medication counseling from a pharmacist is the first listed.

NCT01822171 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01822171 about?

NCT01822171 is a clinical study titled "Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients". Readmission to a hospital shortly after discharge is a common and costly problem. In the United States patients with a diagnosis of heart failure currently experience an elevated 30 day readmission rate of approximately 20%. By providing patients with medication related counseling at discharge by a ...

What is the current status of trial NCT01822171?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2013-01. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01822171?

The interventions under investigation include: Discharge medication counseling from a pharmacist (OTHER), Home medication if needed (OTHER), Follow-up visit at Medication Therapy Management clinic (OTHER).

Who is sponsoring clinical trial NCT01822171?

This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01822171's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01822171, the US trial registry maintained by the National Library of Medicine. NCT01822171 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.